• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
Averhealth logo

Averhealth

Substance use monitoring and treatment solutions.

  • Court Solutions
    • Why Averhealth
    • Our Laboratory
    • Technology
  • Blog
  • Knowledge Hub
    • Press Releases
    • Testimonials
    • Newsletters
    • Annual Reports
    • Webinars
    • Education
      • White Papers
    • Podcast
  • Averhealth Academy
  • About
    • About Averhealth
    • Leadership
    • Careers
    • Job Openings
    • Certifications & Licenses
    • Our Partners
    • Conferences
    • Contact
    • Locations
    • Financial Affordability in Recovery (FAIR) Application
  • Log In
    • Provider
    • Patient

Newsletter Archive


OCTOBER 2024

READ NEWSLETTER


AUGUST 2024

READ NEWSLETTER


JULY 2024

READ NEWSLETTER


JUNE 2024

READ NEWSLETTER


MAY 2024

READ NEWSLETTER

APRIL 2024

READ NEWSLETTER


MARCH 2024

READ NEWSLETTER


FEBRUARY 2024

READ NEWSLETTER


JANUARY 2024

READ NEWSLETTER


SEPTEMBER 2023

READ NEWSLETTER


AUGUST 2023

READ NEWSLETTER


JULY 2023

]
READ NEWSLETTER


JUNE 2023

]
READ NEWSLETTER


MAY 2023

]
READ NEWSLETTER


APRIL 2023

]
READ NEWSLETTER


MARCH 2023

]
READ NEWSLETTER


FEBRUARY 2023

]
READ NEWSLETTER


JANUARY 2023

]
READ NEWSLETTER


DECEMBER 2022

]
  • Mark Johnson named CEO
  • Webinar: Pharmacology of the Mind with Steve Hanson, Jan. 11th
  • CAP-FDT Accreditation: A Badge of Excellence
  • Join us at the 2023 APPA Winter Training Institutes!
  • Season 1 Wrap-Up for our podcast: Recovery Corner
  • Industry News: Fentanyl & Teens – A Dangerous Mix

READ NEWSLETTER


NOVEMBER 2022

Averhealth lab employee testing samples
]
  • Saluting the Achievements of Veterans
  • Veterans Treatment Court Webinar
  • A Veteran Success Story
  • Fentanyl: An Undercover Killer, Learn More About Rainbow Fentanyl
  • What is “ZaZa?” Drug Trends by Jermaine Galloway, the Tall Cop
  • Introducing our Podcast: Recovery Corner
  • Customer tip: Aversys ‘AMA’ Ask Me Anything
  • Industry News: Alcohol Deaths on the Rise

READ NEWSLETTER


OCTOBER 2022

Averhealth lab employee testing samples
]
  • Delivering Quality Assurance
  • Veterans Treatment Court Webinar
  • Upcoming Conferences: Illinois Association of Problem-Solving Courts, October 19-21; Pennsylvania Assoc of Treatment Court Professionals, October 26-28; Washington State Association of Drug Court Professionals and Washington Association of Drug Courts, October 27-28
  • Introducing our Podcast: Recovery Corner
  • Customer tip: Scale Your Service Needs

READ NEWSLETTER


SEPTEMBER 2022

]
  • Keeping up with drug trends
  • SAMHSA National Recovery Month
  • Thanks for visiting us at APPA!
  • Upcoming Conferences: Council of Accountability Court Judges, October 9-12, at Athens, GA; Correctional Management Institute of Texas, October 10-12, at Galveston, TX.
  • Introducing our Podcast: Recovery Corner
  • Blog: SUD & Mental Health: Double Trouble

READ NEWSLETTER


AUGUST 2022

]
  • See You at APPA!
  • Averhealth at NADCP’s RISE22
  • National Pretrial, Probation, and Parole Supervision Week
  • Upcoming Conferences: National Association for Presiding Judges and Court Executive Officers, August 21-24, at Anaheim Hilton in Anaheim, CA; California Probation & Parole & Corrections Association, September 6-9, at the Renaissance Newport Beach Hotel in Newport Beach, CA.
  • Introducing our Podcast: Recovery Corner
  • Blog: A Covert Killer: The Deadly Trend of Fentanyl Lacing

READ NEWSLETTER


JULY 2022

]
  • Introducing the Customer Ambassador Program
  • Opioid Courts Tackling Deadly Problem
  • National Pretrial, Probation, and Parole Supervision Week
  • Upcoming Conferences: NADCP’s RISE22 conference in Nashville, TN July 25-28; Texas Probation Association Legislative Conference in San Antonio, TX, August 7-10
  • Study Identifies Ways to Deliver Jail-Based Addiction Treatment
  • Binge Drinking Prevalent Among Adults

READ NEWSLETTER


JUNE 2022

]
  • Inside a Drug Court Graduation in Henrico County, VA
  • Webinar: “Fentanyl: An Undercover Killer” presented by Gen. Barry McCaffrey (Ret.) and Dominique Delagnes, Averhealth COO
  • Averhealth at NADCP’s RISE22 conference in Nashville, TN July 25-28
  • Upcoming Conferences: West Texas Area Chief’s Association in Fredericksburg, Texas (July 17-19)
  • Study: Urine Drug Tests Correlate with Fatal Overdoses
  • Congressional Bill Focuses on Treatment

READ NEWSLETTER


MAY 2022

]
  • National Drug Court Month Celebrates Successes
  • Blog: Darcy Kamau “Trifecta of Goodness: Working with Purpose to Battle Addiction,” and Brad Bell “Court Gives Veteran a Second Chance at Life”
  • SMS Text Messaging Enhancements for Averhealth Clients
  • Upcoming Conferences: Michigan Association of District Court Probation Officers (May 25-27); NADCP RISE22 in Nashville, TN (July 25-28)
  • Fentanyl Awareness Day
  • DEA Warnings on Fentanyl

READ NEWSLETTER


APRIL 2022

]
  • Coming soon: Text Messaging Enhancements to Increase Client Engagement
  • Blog: Dr. Jermaine Davis “Thriving As A Team”
  • Maricopa County in Arizona Launches Veterans Program
  • Upcoming Conferences: Washington State Misdemeanant Probation Association (May 2-4), Michigan Association of District Court Probation Officers (May 25-27)
  • Six Facts About Alcohol
  • The Danger of Fentanyl-Laced Pills

READ NEWSLETTER


MARCH 2022

]
  • Blog: Help Your Clients Succeed with a Trauma-Informed Approach
  • Drug Trends: Dabbing
  • Upcoming Conferences: MATCP (Missouri, March 30-April 1), MATCP (Michigan, March 30-April 1)
  • National Drug and Alcohol Facts Week
  • LA County Introduces Court for LGBTQ+ Clients
  • Terminology to Help LGBTQ+ Clients Feel Respected Insights & NADCP Webinar Part 2

READ NEWSLETTER


FEBRUARY 2022

]
  • Blog: Assessments and Testing Can Save Us From Being Duped
  • Dispatch from the APPA 2022 Winter Institute
  • Drug Trends: Slang Terms
  • Upcoming Conferences: MATCP (Missouri, March 30-April 1), MATCP (Michigan, March 30-April 1)
  • Drug Overdoses Killing More than 100,000 a Year
  • Alcohol and Cannabis Users Driving Under the Influence

READ NEWSLETTER


JANUARY 2022

]
  • Blog: The Twin Pandemic: Substance Use and Overdoses on the Rise
  • Webinar: Jermaine Galloway, “High in Plain Sight: Current Drug Culture, Trends, and Identifiers”
  • Upcoming Conferences: APPA 2022 Winter Training Institute
  • Department of Justice Awards More than $300 Million to Fight Opioid and Stimulant Crisis and the Address Substance Use Disorders
  • National Suicide Prevention Lifeline to Become a Three-Digit Number–988

READ NEWSLETTER


DECEMBER 2021

]
  • Blog: Staying Safe and Staying Effective: Tools for Recovery in the Era of COVID-19
  • Webinar: Strategies and Tools to Ensure Your Clients Receive the Continuity of Care Needed to Avoid Relapse Through Treatment, Accountability and Safe Sanctions
  • Drug Trends: The Loperamide Trend
  • Wounded Warrior Project Expands Mental Health Treatment to Include Substance Use Disorder Use Prevention Month
  • In Memoriam: Ann Wilson

READ NEWSLETTER

OCTOBER 2021

  • Blog: How to Choose A Drug Testing Partner That Ensures Child Safety In Your Child and Family Services Program
  • Veterans Treatment Court Webinar
  • Shatterproof and The Hartford Release Largest and Most Expansive Addiction Stigma Survey Ever Fielded
  • A Proclamation on National Youth Substance Use Prevention Month, 2021

READ NEWSLETTER

SEPTEMBER 2021

Kathy Waters headshot
]
  • Blog: Evidence Based Practices Begin with Assessments and Much More
  • Drug Trends: Vapes
  • Study: Chatbots Could Help People With Substance Use Disorder Avoid Relapse
  • One Woman’s Inspiring Story of Recovery

READ NEWSLETTER

AUGUST 2021

Medical Marijuana with prescription
]
  • Blog: The Landscape of Legalized and Medical Marijuana: Rocky Navigation for Treatment Courts and Probation Across the Country
  • Drug Trends: Marijuana Concentrates
  • No Change in Adolescent Drug, Alcohol Use During Pandemic
  • All About Substance Use and Bipolar Disorder

READ NEWSLETTER

JULY 2021

male patient with co-occurring disorder
  • Blog: Mental Health and SUD — A Co-Occurring Disorder on the Rise Since 2020
  • Drug Trends: Diphenhydramine
  • How Has the COVID-19 Pandemic Affected Recreational Drug Use?
  • COVID-19’s Continuing Toll: Increasing Alcohol Use and Liver Disease Disproportionately Affect Women

READ NEWSLETTER

JUNE 2021

  • Blog: Positive Language for Stigma Reduction
  • Drug Trends: Kratom
  • Substance Use Disorder: The Power of Acceptance
  • Medicare’s Discriminatory Coverage Policies For Substance Use Disorders

READ NEWSLETTER

MAY 2021

Julie Seymore Treatment Court Administrator for the 11th Judicial Circuit Treatment Court in St. Charles County, Missouri.
  • Blog: We All Have A Story
  • Averhealth Employee Testimonies
  • Drug Trends: What is Delta-8 THC
  • Want to Help Save Lives? End the Stigma Around Substance Use Disorders

READ NEWSLETTER

APRIL 2021

  • Blog: Alcohol Testing With EtG/EtS Detects Ethanol Better Than Simple Alcohol Testing
  • More Older People Being Admitted to Hospital for Alcohol-Related Reasons Amid Concerns Over Lockdown BoozingHouse
  • People With Substance Use Disorders Face Barriers To Getting COVID Vaccine
  • House Subcommittee Holds Hearing on Opioid Epidemic Within the COVID-19 Pandemic

READ NEWSLETTER

MARCH 2021

Drug-Impaired driver operating a car
  • Blog: Beyond Alcohol — The Challenges of Supervising the Drug Impaired Driver
  • COVID And Drug Trends: The Past, Current and Possible Future Relationship!
  • Younger Age of First Cannabis Use or Prescription Drug Misuse Is Associated With Faster Development of Substance Use Disorders
  • SAMHSA Boosts State Aid in Mental Health, Substance Abuse

READ NEWSLETTER

FEBRUARY 2021

Averhealth's Laboratory in St. Louis, MO
  • The Importance of Lab-Based Testing for Accuracy and Reliability
  • Webinar: Beyond Alcohol — The Challenges of Supervising the Drug Impaired Driver
  • Data-Driven: How Technology Can Improve Psychiatric Practice
  • Treating Substance Use Disorders and PTSD
READ NEWSLETTER

DECEMBER 2020

  • Struggling with SUD for the Holidays
  • Drug Trends: Vapes
  • Coming Soon: APPA Webinar
  • APPA Webinar – Presented by Douglas B. Marlowe, J.D., Ph.D.
  • In Memoriam: The Honorable Ruben Reyes
READ NEWSLETTER

NOVEMBER 2020

Girl dealing with the stress and loneliness of addiction during COVID-19.
  • Dealing with the Addiction Crisis During the Nightmare of COVID-19
  • Drug Trends: Marijuana Concentrates
  • Coming Soon: APPA Webinar
  • Rising Stimulant Deaths Show that We Face More than Just an Opioid Crisis
  • Kentucky seeks to be first in the nation to treat substance use disorder in prisons using Medicaid dollars
READ NEWSLETTER

OCTOBER 2020

  • Drug and Alcohol Testing in Community Corrections: Some Provocative Findings
  • NADCP Webinar featuring Maricopa County
  • NADCP Congratulates Federal Grant Award Recipients
  • Indiana University Researcher Helping At-Risk Students Steer Away from Substance Use Disorder
  • DEA Pressured to Create a Telehealth Registration for Drug Abuse Treatment
READ NEWSLETTER

SEPTEMBER 2020

  • Evidence-Based Practices for Substance Use Disorder Testing
  • Drug Trends: Marijuana
  • Substance use disorder impacts a whole family
  • Look beyond opioids to solve national substance use epidemic
  • Substance use disorders linked to COVID-19 susceptibility
READ NEWSLETTER

AUGUST 2020

The Impact of SUD and Mental Health on Healthcare Costs
  • The Impact of SUD and Mental Health on Healthcare Costs
  • Customer Testimonial
  • Drug Trends: Kratom
  • St. Charles County Treatment Court Celebrates 20 Years of Providing Second Chances
  • COVID-19 and the opioid crisis: When a pandemic and an epidemic collide
  • Shatterproof launches free addiction treatment locator tool with backing from Aetna, Anthem, Cigna and UnitedHealth
READ NEWSLETTER

JULY 2020

Drug Testing during COVID-19 requires Averhealth employees to wear PPE
  • 5 Solutions for Drug Testing during COVID-19
  • Customer Testimonial
  • How Bangor Drug Court participants are getting help staying sober during the pandemic
  • The Significance of Vermont’s Justice Reinvestment Legislation
  • Pretrial, Probation, and Parole Supervision Week
READ NEWSLETTER

JUNE 2020

  • Averhealth’s Testing Solutions During a Crisis
  • Chester County Drug Court Continues Testing
  • Averhealth’s Webinar
  • Averhealth — Proud Platinum Sponsor of NADCP All RISE20 Virtual
  • COVID-19 is Causing People to Relapse
  • 75,000 Americans at risk of dying from overdose or suicide due to coronavirus despair, group warns
  • Returning to resilience: The impact of COVID-19 on mental health and substance use
READ NEWSLETTER

Primary Sidebar

BLOG SEARCH

Join Our Newsletter

Be the first to find out when we have exclusive news, articles or upcoming events to share.

Footer

  • Facebook
  • LinkedIn
 
866. 680. 3106
info@Averhealth.com

Newsletter Signup

Averhealth, Avertest, Aversys, and the associated logos and all associated marks are registered trademarks or service marks of Avertest, LLC. © 2025 Avertest, LLC. All rights reserved.

  • Lab Certifications
  • Non-Discrimination Notice
  • Compliance
  • Privacy Policy
  • texas Department of information resources
  • SAM registration